ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2009
Diagnosis and management of benign prostatic hyperplasia in primary care.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials.PLoS medicine · 2021Pooled it
- Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial.PloS one · 2013Trial
- Article
- Acute Oral Toxicological Profile ofJournal of toxicology · 2024Article
- Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.American journal of clinical and experimental urology · 2022Review
- The role of preoperative dutasteride in reducing bleeding during transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials.Asian journal of urology · 2022Article
- Prostate Artery Embolization-Review of Indications, Patient Selection, Techniques and Results.Journal of clinical medicine · 2021Review
- Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.International journal of clinical practice · 2021Observational
- Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.International journal of clinical practice · 2020Article
- Article
- HBX-6, StandardizedMolecules (Basel, Switzerland) · 2019Article
- [Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].Der Urologe. Ausg. A · 2019Review
- MRI-based method for lower urinary tract dysfunction in adult male mice.American journal of clinical and experimental urology · 2019Article
- Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.Molecules (Basel, Switzerland) · 2018Article
- Impact of oral capsule ofJournal of renal injury prevention · 2017Article
- Clinical effects of discontinuing 5-alpha reductase inhibitor in patients with benign prostatic hyperplasia.Korean journal of urology · 2014Article
- Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.World journal of urology · 2012Article
- Benign prostatic hyperplasia: An overview of existing treatment.Indian journal of pharmacology · 2011Article
- The aging male population and medical care for benign prostatic hyperplasia in Canada.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign prostatic hyperplasia (BPH), and its clinical manifestation as lower urinary tract symptoms (LUTS), is a major health concern for aging men. There have been significant advances in the diagnosis and treatment of BPH in recent years. There has been a renewed interest in medical therapies and less invasive surgical techniques. As a consequence, the treatment needs of men with mild to moderate LUTS without evidence of prostate cancer can now be accomplished in a primary care setting. There are differences in the way urologists and primary care physicians approach the evaluation and management of LUTS due to BPH, which is not reflected in Canadian Urological Association (CUA) and American Urological Association (AUA) guidelines. A "shared care" approach involving urologists and primary care physicians represents a reasonable and viable model for the care of men suffering from LUTS. The essence of the model centres around educating and communicating effectively with the patient on BPH. This article provides primary care physicians with an overview of the diagnostic and management strategies outlined in recent CUA and AUA guidelines so that they may be better positioned to effectively deal with this patient population. It is now apparent that we must move away from the urologist as the first-line physician, and allow primary care physicians to accept a new role in the diagnosis and management of BPH.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.